Paul Saladino· MD
but context our underlying metabolic health determines everything when it comes to gout when it comes to apoe4 when it comes to the atherogenicity or the participation in the formation of an atheroma of an ldl molecule
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but context our underlying metabolic health determines everything when it comes to gout when it comes to apoe4 when it comes to the atherogenicity or the participation in the formation of an atheroma of an ldl molecule
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there's clearly a third variable just like there's a third variable with ldl there's a third variable with gap it's all about context what is that third variable a third variable is metabolic dysfunction